[Neurological complications during therapy with 17 MDCAA (author's transl)]

A case of a 39 years old woman on therapy with Monodicloroacetilajmaline for repetitive crises of Ventricular Tachycardia is shown. We have observed neurological symptoms by central compromission of 3rd, 4th, 6th pair of cranial nerves, cutaneous symptoms and a neurodisletic crisis. We particularly analyse the dosage of the drug in relation to the progression of symptoms and also the possible pathogenesis. Symptoms disappeared completely about 20 days after withdrawal of the drug.